Retatrutide Ramadan Protocol UAE: Suhoor, Iftar, Hypoglycaemia Mitigation & Dose Adjustment (2026)

Why Ramadan Changes the Retatrutide Calculus

Retatrutide is a triple agonist at GLP-1, GIP and glucagon receptors with a ~6-day half-life (Coskun 2022). Once weekly dosing produces a relatively flat exposure curve, but appetite suppression, delayed gastric emptying and glucagon-driven hepatic glucose output all interact with caloric timing. During Ramadan, UAE researchers face three problems simultaneously:

• 16–17 hours daily without food or water from suhoor (~03:30) to iftar (~19:15) in Dubai during peak summer Ramadan.
• Two compressed eating windows — iftar through to suhoor — during which all caloric intake must occur.
• Heat-driven dehydration, particularly outside air-conditioned environments, on top of GLP-1 induced thirst blunting.

The Jastreboff 2023 NEJM trial did not enrol fasting subjects, so all Ramadan adjustments are extrapolated from GLP-1 fasting literature (largely semaglutide and liraglutide — Wilding 2021, Hassanein 2020 in the DAR International Alliance dataset) plus mechanism-of-action reasoning around the glucagon arm.

Injection Timing — Suhoor vs Iftar Coordination

The single highest-leverage decision is when in the 24-hour cycle to inject. Three options, with the trade-offs:

The default UAE recommendation is post-iftar between 21:00 and 23:00 GST. This places the peak plasma rise (~Tmax 24–48 h for SC peptides of this class — Drucker 2022) and the peak nausea window during hours when the subject can drink water, eat small frequent meals and lie down. Suhoor injection is the worst option for most subjects because it loads side effects into the fasting day when no rescue food or fluid is available.

Dose Adjustment Options for the Fasting Month

Three legitimate strategies, depending on where the subject is in their titration curve:

Strategy A — Hold current dose (most common)

• For subjects already stable at 4 mg, 8 mg or 12 mg weekly with good tolerance prior to Ramadan.
• No dose change; only shift injection day/time to post-iftar.
• Pause titration plans until after Eid al-Fitr.

Strategy B — Step down one dose

• For subjects who have experienced nausea, dehydration sensitivity or postural symptoms at their current dose.
• Drop one increment (e.g., 8 mg → 4 mg) for the four weeks of Ramadan, then resume.
• Conservative; preserves protocol integrity while reducing GI burden during fasting.

Strategy C — Pause titration for new starters

• For subjects who initiated retatrutide within ~8 weeks of Ramadan.
• Hold at 0.5 or 1 mg for the entire fasting month; do not escalate.
• Resume the standard retatrutide titration schedule after Eid.

No published data support increasing dose during Ramadan, and no UAE protocol should do so. The interaction of caloric restriction, dehydration and triple-agonist pharmacology is not characterised in trial subjects.

Hypoglycaemia Mitigation in the Fasting Day

Retatrutide as monotherapy has a low intrinsic hypoglycaemia signal. The Rosenstock 2023 Lancet T2D trial reported hypoglycaemia rates comparable to placebo in subjects not on insulin or sulfonylureas — mechanism: the glucagon-receptor arm raises hepatic glucose output, partially offsetting GLP-1 mediated insulin release (Müller 2019). For UAE research subjects, the practical risks are:

1. Stacked therapy. Subjects also on basal insulin, glinides or sulfonylureas need those agents down-titrated before Ramadan — IDF-DAR 2021 guidance applies.
2. Inadequate suhoor caloric load. Skipping suhoor or eating only carbohydrate (no protein, no fat) shortens the runway and increases late-afternoon dip risk.
3. Heat-driven volume depletion mimics hypoglycaemia symptomatically (light-headedness, fatigue) — always check glucose before assuming the cause.
4. First Ramadan exposure. Subjects new to retatrutide during a fasting month should run continuous glucose monitoring (CGM) for at least the first two weeks.

Symptom education: subjects should break the fast (Islamic ruling permits this for medical safety) at the first signs of objective hypoglycaemia — sweating, tremor, confusion, glucose <3.9 mmol/L. A 15 g rapid carbohydrate at iftar timing is the standard rescue.

Hydration, Electrolytes and Heat — the UAE Layer

Ramadan in the UAE summer is uniquely demanding because of heat. GLP-1 class agents are associated with subtle thirst-signal blunting (Stanley 2022 review on entero-hormonal satiety), which compounds the no-water constraint of the fasting day. Practical mitigations:

• Iftar to suhoor hydration target: 2.5–3.0 L of fluid, paced over the window — not consumed in the first hour.
• Electrolytes at suhoor — sodium and potassium replacement, particularly for subjects working outdoors or in hot environments.
• Avoid caffeine after iftar if it disturbs sleep, since sleep deprivation worsens GLP-1 induced fatigue.
• Move outdoor activity to post-iftar hours; this is standard practice for UAE residents and especially relevant for retatrutide subjects.

For deeper coverage of UAE storage and heat handling, see the peptide fridge storage UAE guide.

Where to Buy Retatrutide in the UAE — 24h Delivery

REVIVE Peptides operates from a Dubai cold-chain facility with retatrutide 5 mg and 10 mg vials held in continuous 2–8 °C storage. Ramadan ordering hours shift but dispatch continues seven days a week. Per-emirate delivery windows:

Cold-chain protocol: vials are dispatched in insulated boxes with phase-change gel packs validated to hold 2–8 °C for up to 24 hours of transit, even in summer ambient. Each shipment includes the HPLC certificate of analysis for the specific lot. The full REVIVE UAE peptide range ships under the same logistics.

Ordering process is direct: choose your vial strength on the retatrutide product page, select your emirate, and confirm. Most subjects buying retatrutide UAE 24h delivery during Ramadan order at iftar so the next-day delivery arrives in time for the weekly injection window.

Putting It Together — a Worked Ramadan Week

A typical UAE research subject on 8 mg weekly retatrutide, Friday injection day:

1. Thursday 14:00 GST — order replacement vial from REVIVE Dubai; same-day delivery confirmed.
2. Friday 19:15 — iftar; balanced meal, slow eating, hydration paced.
3. Friday 21:30 — retatrutide 8 mg SC injection, abdomen rotation site.
4. Friday 22:00–02:00 — small frequent meals, ginger tea if early nausea, 2 L water spread.
5. Saturday 03:30 — suhoor with protein + complex carbohydrate + electrolyte beverage.
6. Saturday day — fast as normal; expect mild residual appetite suppression to help.
7. Sun–Thu — standard fasting cycle; CGM if first Ramadan exposure.

Companion reading: titration schedule, reconstitution math, and GLP-1 nausea mitigation.